With the economic conditions going uncertain and an increase in unemployment, dividend stocks are key stakes to hold especially for income investors. 2021 will certainly be the year of dividend-paying stocks.
The pandemic has hit hard at the bottom-levels of society.Especially, those people have been hurt badlywho made their living on monthly income. That’s where dividend stocks play a key role for such people who want to invest in stocks.
As we head in 2021, the overall economy is more likely to see toweringgrowth. Most probably, the vaccine will be available by the end of this year in the U.S. as things are expected to get better in the upcoming year.
In that premise, there are a couple of dividend stocks to buy in 2021; stocks with a prominent dividend yield. Let’s have a look at the two-best dividend-paying stocks for 2021.
Realty Income (O)
Realty Income (O) is a classic monthly dividend firm and a definitivereal estate investment trust. The company delivered its 604th consecutive common stock monthly dividend, as of the press release on Oct. 15, 2020.
With a reasonable price of $61.75 per share, Realty Income stock is the perfect dividend stock to go with. The company continued to paymonthly dividends despite the unprecedented economic circumstances due to COVID-19. The collection of 94% rent in September reflects a strong business model of the company.
Realty Income calls itself “The Monthly Dividend Company” as its official nickname. The company has a dividend yield of 4.56%, as we write this. However, the key aspect is its consistency which makes Realty Income stockone of the best dividend stocks to invest in.
Moreover, Realty Income’s dividend has grown at arate of 4.5% annually since its IPO in 1994.With things getting better, Realty Income is the best dividend stock to go for in 2021.
A young pharma titan, AbbVie (ABBV) is one of the favorites for dividend investors. The company has surged over 23% this year so far. The stock has a market value ofjust over $180 billion, which dropped over $5 billion during the last five days. The point here is that there is upside potential for the stock to continue its growth.
This provides a golden opportunity for investors to buy ABBV stock at a comparatively low price.
AbbVie is an exciting pharma company because of its highly popular drug, Humira, which treats patients with arthritis, plaque psoriasis, and Crohn’s disease. The biological products of the company have theirsignificance in the market at a large scale. The overall portfolio of the company is quite impressive.
AbbVie has become an attractive investment for investors due to its high profitability and consistently growing revenues. The company yields at 5.06% and is another favorite dividend stock to look for in 2021.